LINC02132

Across TCGA pan-cancer cohorts, LINC02132 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02132’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02132 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02132 is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

KIRC, KICH, and COAD are the cancer types where LINC02132 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02132 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.216	<.001	11	view →
KICH	All	II,III,IV	−0.186	<.001	8	view →
COAD	Female	All	−0.296	<.001	6	view →
LUSC	All	All	−0.253	<.001	5	view →
THCA	All	All	−0.468	<.001	4	view →
LUAD	All	III,IV	−0.162	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02132–KIRC

Open the KIRC breakdown →